Among the companies whose shares are expected to see active trading Monday are Apple, Citigroup and Exxon Mobil

The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.

MINNEAPOLIS----The U.S. Food and Drug Administration Neurological Devices Panel today voted seven to five to recommend approval with conditions of Deep Brain Stimulation Therapy for Epilepsy from Medtronic, Inc. as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy.

Federal health advisers say a brain stimulating device from Medtronic can be approved for epilespy, provided the company conducts follow-up safety studies.

PLAVIX PROBLEM: The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.

Medical device maker Medtronic Inc. has announced an offering of senior notes totaling $3 billion for working capital and general corporate purposes.

Big Drug Firms Most Exposed to Generics Credit Suisse says AstraZeneca, Lilly and Bristol-Myers are the most at risk.

MINNEAPOLIS----Moving to expand the evidence base for the future of structural heart disease therapy, Medtronic, Inc. , today announced the start of the first of several new initiatives in a robust international clinical program for its CoreValve transcatheter aortic valve system, a minimally-invasive alternative to open-heart surgery for aortic valve replacement.